Vimarsana
Biggest News Aggregation in the World

Page 3 - Borja Ib News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Borja Ib. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Borja Ib Today - Breaking & Trending Today

Royal Philips: Philips spotlights smart diagnostic and treatment solutions driving clinical confidence and workflow efficiency at ESC 2021 - Vimarsana News

Royal Philips: Philips spotlights smart diagnostic and treatment solutions driving clinical confidence and workflow efficiency at ESC 2021

August 26, 2021 Company's innovative, integrated imaging systems, devices, software, informatics and services support greater efficiency, enabling high-quality care for a growing volume of complex

Investegate |Royal Philips Announcements | Royal Philips: Philips spotlights smart diagnostic and treatment solutions driving clinical confidence and workflow efficiency at ESC 2021 - Vimarsana News

Investegate |Royal Philips Announcements | Royal Philips: Philips spotlights smart diagnostic and treatment solutions driving clinical confidence and workflow efficiency at ESC 2021

Investegate announcements from Royal Philips, Philips spotlights smart diagnostic and treatment solutions driving clinical confidence and workflow efficiency at ESC 2021

RESILIENCE project aims to reduce the burden of cardiovascular disease in cancer survivors - Vimarsana News

RESILIENCE project aims to reduce the burden of cardiovascular disease in cancer survivors

RESILIENCE project aims to reduce the burden of cardiovascular disease in cancer survivors Cancer patients are a vulnerable population prone to develop cardiovascular complications. Among other factors, some anticancer therapies can induce adverse cardiovascular effects. Every year, more than 3 million Europeans receive anthracyclines alone or in combination with other anticancer agents. Anthracyclines are a frequently prescribed anticancer agent that can induce an irreversible toxic effect on the heart may lead to chronic heart failure in  ≈5% of the cases. It is estimated that in Europe ...

RESILIENCE, a project to reduce prevalence of heart failure in cancer survivors - Vimarsana News

RESILIENCE, a project to reduce prevalence of heart failure in cancer survivors

European Society of Cardiology Madrid, 30 June 2021. Cancer patients are a vulnerable population prone to develop cardiovascular complications. Among other factors, some anticancer therapies can induce adverse cardiovascular effects. Every year, more than 3 million Europeans receive anthracyclines alone or in combination with other anticancer agents. Anthracyclines are a frequently prescribed anticancer agent that can induce an irreversible toxic effect on the heart may lead to chronic heart failure in ≈5% of the cases. It is estimated that in Europe the prevalence of chronic heart failure ...

The first blood biomarker to distinguish between myocarditis and acute myocardial infarction - Vimarsana News

The first blood biomarker to distinguish between myocarditis and acute myocardial infarction

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have identified the first blood biomarker for myocarditis, a cardiac disease that is often misdiagnosed as myocardial infarction. The study is published today in The New England Journal of Medicine.